The expanding role of PET technology in the management of patients with colorectal cancer

被引:21
作者
Herbertson, R. A. [1 ,2 ]
Lee, S. T. [1 ,3 ,4 ]
Tebbutt, N. [1 ,2 ]
Scott, A. M. [1 ,3 ,4 ]
机构
[1] Univ Melbourne, Ludwig Inst Canc Res, Melbourne Ctr Clin Sci, Heidelberg, Vic, Australia
[2] Univ Melbourne, Ludwig Inst Oncol Unit, Heidelberg, Vic, Australia
[3] Univ Melbourne, Ctr Positron Emiss Tomog, Heidelberg, Vic, Australia
[4] Univ Melbourne, Dept Med, Heidelberg, Vic, Australia
关键词
colorectal cancer; positron emission tomography;
D O I
10.1093/annonc/mdm108
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The therapeutic options and subsequent survival of colorectal cancer (CRC) patients has increased substantially over recent years. While surgical excision of the primary cancer results in cure of similar to 50% of patients, recurrence and metastatic disease still remains a significant cause of death. Although resection of liver or lung metastases can result in cure, relapse rates remain high, indicating that patient selection needs improvement. Positron emission tomography (PET) technology has a great deal to offer with respect to CRC management, particularly in the setting of patient selection for metastasectomy and in the evaluation of possible recurrent disease, however it has not yet become a routine part of the management of all CRC patients. This review article aims to discuss the current and future implications of PET technology in the optimal management of CRC patients throughout their care pathway.
引用
收藏
页码:1774 / 1781
页数:8
相关论文
共 62 条
[1]   Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET [J].
Antoch, G ;
Saoudi, N ;
Kuehl, H ;
Dahmen, G ;
Mueller, SP ;
Beyer, T ;
Bockisch, A ;
Debatin, JF ;
Freudenberg, LS .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) :4357-4368
[2]   The impact of FDG-PET on the management algorithm for recurrent colorectal cancer [J].
Arulampalam, T ;
Costa, D ;
Visvikis, D ;
Boulos, P ;
Taylor, I ;
Ell, P .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) :1758-1765
[3]  
Bar-Shalom R, 2003, J NUCL MED, V44, P1200
[4]   Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - Meta-analysis [J].
Bipat, S ;
van Leeuwen, MS ;
Comans, EFI ;
Pijl, MEJ ;
Bossuyt, PMM ;
Zwinderman, AH ;
Stoker, J .
RADIOLOGY, 2005, 237 (01) :123-131
[5]   Investing in new technology: the PET experience [J].
Bradbury, I ;
Facey, K ;
Laking, G ;
Sharp, P .
BRITISH JOURNAL OF CANCER, 2003, 89 (02) :224-227
[6]  
Bruehlmeier M, 2004, J NUCL MED, V45, P1851
[7]  
*CFMAM MED, 2000, SERV UDOHAH
[8]  
Cher LM, 2006, J NUCL MED, V47, P410
[9]   Trends in long-term survival following liver resection for hepatic colorectal metastases [J].
Choti, MA ;
Sitzmann, JV ;
Tiburi, MF ;
Sumetchotimetha, W ;
Rangsin, R ;
Schulick, RD ;
Lillemoe, KD ;
Yeo, CJ ;
Cameron, JL .
ANNALS OF SURGERY, 2002, 235 (06) :759-765
[10]   Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):: A feasibility study [J].
Ciernik, IF ;
Dizendorf, E ;
Baumert, BG ;
Reiner, B ;
Burger, C ;
Davis, JB ;
Lütolf, UM ;
Steinert, HC ;
Von Schulthess, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03) :853-863